Immunoassay support for the Vaxxas Nanopatch phase 1 clinical trial (SP-1207-022): assessment of CMI (2018–2019)
- Grant type:
- UniQuest Pty Ltd
- Researchers:
-
-
- Funded by:
- UniQuest Pty Ltd
